Kotter's 8-Step Change Model

Step 1 - Create urgency (the burning platform was invisible from inside a profitable business)

Adobe was not losing money. That is exactly the complacency Kotter warns about — no crisis, no urgency, no change. The urgency had to be manufactured from structural facts: revenue was flat around 4 billion dollars for several years, roughly half the paying installed base was running an old version because the upgrade decision was a 1,300 dollar re-purchase every two years, piracy meant a large share of actual users paid nothing, and the entire year's number depended on whether one big release landed well. Narayen's framing was not 'we are dying', it was 'the model caps us' — the opportunity half of urgency. If you own the customer relationship monthly instead of biennially, you learn what they use, you can ship continuously, and you convert the students and freelancers who were never going to pay 2,600 dollars upfront.

Step 2 - Build the guiding coalition (the non-obvious member is the CFO)

Most students would put the product leader at the centre. The binding constraint here was accounting, so the coalition's most important member after Narayen was CFO Mark Garrett. Under revenue recognition rules, a 1,300 dollar licence books immediately while a 49.99 dollar subscription books over 12 months — so a successful transition looks identical to a collapsing business for about two years. Garrett's job was to build and pre-sell a second scoreboard before the numbers went negative. The coalition therefore spanned CEO, CFO, investor relations, David Wadhwani's digital media product organisation, and sales leadership — and it had a second, external audience the coalition had to convert: sell-side analysts and large institutional holders, who could kill the programme by punishing the stock hard enough to force a reversal.

Step 3 - Form the strategic vision

The one-line version: every creative on the latest version, all the time, connected. Concrete and directional, not 'become a cloud-first company'. The strategy underneath was three moves. One, kill perpetual entirely rather than run both models — a hybrid would have let sales and customers stay on the old rails indefinitely, which is precisely how transformations die. Two, price to widen the funnel: 49.99 a month drops the entry barrier from a 2,600 dollar capital decision to a credit-card decision, and the later 9.99 photography plan pulled in a long tail that Creative Suite never monetised. Three, change the scoreboard to annualised recurring revenue, subscriber count and churn.

Steps 4 and 5 - Enlist and remove barriers (four real blockers, four structural fixes)

Barrier one: sales compensation paid on licence bookings, so every rep was economically punished for selling a subscription — quotas and comp were rebased onto subscriptions and recurring revenue. Barrier two: the reseller and channel partners made their margin selling boxes and had no reason to push a direct-billed subscription — they were moved to recurring commission so their incentive followed the customer. Barrier three: the reported P&L would look like failure, so guidance shifted to a published multi-year subscriber and ARR model with quarterly subscriber disclosure, giving investors a metric that went up while GAAP revenue went down. Barrier four: customers were genuinely angry — a petition drew tens of thousands of signatures — so Adobe conceded loyalty pricing for existing CS owners and later the 9.99 photography plan, absorbing the anger at the low end rather than arguing with it.

Step 6 - Generate short-term wins

The engineered win was the subscriber count itself, reported every single quarter. That is the whole trick: Adobe took a metric that would move up monthly and made it the public scoreboard, so that during the two years when revenue was falling there was always a number going in the right direction to point at. Roughly 1.4 million paid subscribers by the end of FY2013 and about 3.4 million a year later meant every quarterly call delivered visible progress. Internally it did the same job — a rep who could see net-new subscribers beating plan stopped believing management had broken the business. Compare this with a programme whose first proof point is 18 months out; belief does not survive 18 months of silence.

Step 7 - Sustain acceleration

When revenue turned back up — roughly 4.15 billion in FY2014 and about 4.8 billion in FY2015, passing the old peak — the tempting move was to declare victory. Instead the coalition spent that restored credibility on the work it could never have got approved in 2012: Acrobat was converted into Document Cloud on the same recurring model, the Omniture and later Marketo assets were built into a second recurring engine in Experience Cloud, and the engineering organisation moved from big biannual releases to continuous shipping. Each of those was a harder internal fight than the original Creative Cloud decision, and each was winnable only because the first change had visibly worked.

Step 8 - Anchor in culture

Recurring revenue became the operating language, not a finance metric: planning, product roadmaps and compensation were all built around net-new ARR, retention and churn rather than release dates. The release calendar, which had organised the company's identity for two decades, disappeared — there is no 'CS7', and a team that ships monthly cannot revert to a boxed-product culture even if it wanted to. New hires arrived into a company where nobody had ever shipped a box. That is the test of step 8: the change now survives the departure of every person who led it.

Step 1 - Create urgency, but build two different burning platforms

The corporate urgency — 2,400 crore rupees paid at a multiple that only works if 180 crore of synergy lands — is meaningless to a cardiologist, and leading with it actively harms you because it says 'we bought you'. So build two fact bases. For the board and corporate teams: at the current run rate the deal returns roughly a third of underwritten synergy and the acquired asset is physically walking out of the building at 9 senior consultants in 14 months. For the clinicians, urgency must be clinical and comparative: unwarranted variation across the merged group — say door-to-balloon time of 92 minutes at Lucknow against 68 at the Chennai flagship, C-section rate of 38 percent at one unit against 24 percent at another, and readmission rates that differ by a factor of two for the same procedure. Add the external squeeze that every Indian hospital feels: insurer and CGHS package rates are flat or falling while consumables inflate, so cost per bed-day is not a corporate obsession, it is survival.

Step 2 - Build the guiding coalition around clinical credibility, not the org chart

In a hospital, formal authority and real power are decoupled: patients follow the consultant, not the brand, and a senior surgeon with a 22-year personal patient book can take 15 crore rupees of annual revenue across the road. So the CEO cannot chair this. The coalition is chaired by the Group Chief Medical Officer, and its most important member is Sanjeevani's senior-most cardiac surgeon — the loudest sceptic and the largest individual revenue source — who is handed ownership of the clinical council rather than being managed around. Add the Chennai flagship's chief of oncology (the hub's credibility), the north-cluster COO (budget and line authority), the group procurement head, and the nursing director, because nurses actually execute protocols. Set one non-negotiable operating rule: no protocol is adopted unless a doctor of equal standing proposes it. Peer to peer, never corporate to clinical.

Step 3 - Form the strategic vision

One line, said out loud in the interview: 'The same standard of care in Lucknow as in Chennai — and your practice grows because of it.' The second clause is doing the heavy lifting, exactly as the redundancy promise does in a plant closure, because the unspoken consultant fear is that standardisation means lower income and lost autonomy. Make it concrete: top-quartile outcomes on 12 tracked clinical metrics across all 20 hospitals by FY29, ALOS at 4.0 days, and no consultant's case volume down year on year. The strategy is three moves — a joint clinical council owning 12 high-volume protocols, one formulary and one procurement spine, and a hub-and-spoke referral system with an explicit revenue share.

Steps 4 and 5 - Enlist the army and remove the barriers that are actually biting

This is where the case is won, because every stalled synergy traces to a structural blocker, not to attitude. Blocker one: Sanjeevani consultants are on fee-for-service per procedure, so a protocol that cuts length of stay and drops unnecessary investigations directly cuts their income — they are behaving rationally. Fix: a blended contract, guaranteed minimum plus an outcomes-and-volume bonus, so protocol compliance stops being a pay cut. Blocker two: refer a patient to Chennai and you lose the patient, the relationship and the fee forever — fix with a referral fee-share plus a written and enforced rule that the patient returns to the referring consultant post-procedure, tracked in a shared referral module. Blocker three: procurement is stuck because doctors have genuine implant and stent brand preferences and unit purchase managers hold local vendor relationships — so give formulary decisions to the clinical council rather than to finance, since doctors will accept rationalisation from doctors. Layer communication on top: monthly grand rounds rotating city to city, the CMO physically present at each unit, and a group clinical WhatsApp channel.

Step 6 - Generate short-term wins, chosen for who presents them

Pick one clinical and one financial win landing inside six months, both attributable to Sanjeevani rather than to the acquirer. Clinical: run the flagship's cath-lab protocol at Lucknow and take door-to-balloon from 92 to about 65 minutes with PCI length of stay from 3.2 to 2.1 days — a result that is unambiguously good medicine, which makes it politically unarguable. Financial: rationalise stents and high-value consumables from nine vendors to three under clinical-council sign-off, banking roughly 18 crore rupees annualised. Then the step that actually matters: the Sanjeevani cardiac surgeon presents both results at the group review, not the CEO and not the integration PMO. You have converted your biggest sceptic into your most credible advocate, and every other consultant now sees the change as clinician-led.

Step 7 - Sustain acceleration by spending the credibility on the hard items

Only now attack what would have caused walkouts in month one: a common EMR across all 20 hospitals, a single credentialing and clinical-privileges framework, migrating north-cluster complex oncology to the Chennai hub, closing a duplicated cath lab in NCR, and renegotiating the two largest insurer contracts as one 4,200-bed entity rather than two chains. Note the sequencing logic — insurer renegotiation is the single largest value pool and it needed the merged clinical data and outcomes credibility that steps 5 and 6 produced. Do not let the PMO announce that integration is complete when procurement hits its number; that declaration is what allows local purchase habits and old protocols to quietly return.

Step 8 - Anchor in culture

The monthly business review opens on a clinical dashboard — ALOS, infection rate, readmission, protocol compliance by unit — before the P&L, which signals what the group actually optimises for. Consultant contract renewals carry protocol compliance and outcome metrics as explicit criteria, so the incentive is permanent rather than programme-linked. New consultant onboarding runs through the clinical council, and the DNB and residency programme teaches the group protocols as the default, so the next clinical generation never practises another way. At that point the integration survives the CMO who led it, which is the only real test of step 8.